Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0I7E stock hub

LON/0I7E has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0I7Eis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

9.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0I7E

In the news

Latest news · LON/0I7E

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9

P25 12.9P50 16.9P75 23.5

Trailing P/E15.8

P25 15.9P50 22.9P75 35.8

ROE81

P25 -54.2P50 2.1P75 13.7

ROIC12.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0I7E market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	78,000
Employees Change	6,000%
Employees Change Percent	8.57
Enterprise value	$19.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US23918K1088
Last refreshed	2026-05-10
Market cap	$9.4B
Price	$196
Price currency	USD
Rev Per Employee	134,325.4x
Sector	Healthcare
Sic	8090
Symbol	lon/0I7E
Website	https://www.davita.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.32%
EV Earnings	33.62x
EV/EBIT	12.84x
EV/EBITDA	7.67x
EV/FCF	17.6x
EV/Sales	1.96x
FCF yield	12.08%
Forward P/E	12.86x
P/B ratio	11.79x
P/E ratio	15.82x
P/S ratio	0.89x
PE Ratio10 Y	19.21x
PE Ratio3 Y	14.15x
PE Ratio5 Y	13.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.01%
EBITDA Margin	20.19%
FCF margin	10.79%
Gross margin	32.45%
Gross Profit	$3.4B
Gross Profit Growth	6.67%
Gross Profit Growth Q	9.09%
Gross Profit Growth3 Y	9.54%
Gross Profit Growth5 Y	4.65%
Net Income	$591.8M
Net Income Growth	-9.1%
Net Income Growth Q	21.25%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	15%
Net Income Growth5 Y	0.26%
Pretax Margin	10.13%
Profit Margin	5.65%
Profit Per Employee	$7,587
Profitable Years	14
ROA	7.5
Roa5y	6.34
ROCE	14.19
ROE	80.98
Roe5y	46.91
ROIC	12.06
Roic5y	10.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	36.36%
Cagr3y	30.42%
Cagr5y	9.23%
EPS Growth	6.22
EPS Growth Q	43.5
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	25.13
EPS Growth5 Y	10.67
FCF Growth	-15.15%
FCF Growth Q	495.39%
FCF Growth3 Y	11.5%
FCF Growth5 Y	6.13%
OCF Growth	-13.25%
OCF Growth Q	78.23%
OCF Growth10 Y	2.55%
OCF Growth3 Y	5.94%
OCF Growth5 Y	2.72%
Revenue Growth	6.68x
Revenue Growth Q	5.96x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	5.85x
Revenue Growth5 Y	3.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.8
Assets	$13.3B
Cash	$504.8M
Current Assets	$3B
Current Liabilities	$2.1B
Debt	$10B
Debt EBITDA	$3.78
Debt Equity	$12.61
Debt FCF	$8.86
Equity	$793.8M
Interest Coverage	3.59
Liabilities	$12.5B
Long Term Assets	$10.3B
Long Term Liabilities	$10.4B
Net Cash	$-9.5B
Net Cash By Market Cap	$-102
Net Debt EBITDA	$4.5
Net Debt Equity	$11.98
Net Debt FCF	$8.41
Tangible Book Value	$-6.5B
Tangible Book Value Per Share	$-98.02
WACC	6.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	63.98
Net Working Capital	$813M
Quick ratio	1.28
Working Capital	$905.1M
Working Capital Turnover	$10.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	14.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	36.33%
200-day SMA	134
3Y total return	121.87%
50-day SMA	154.1
50-day SMA vs 200-day SMA	50over200
5Y total return	55.48%
All Time High	200
All Time High Change	-2.21%
All Time High Date	2026-05-08
All Time Low	44.5
All Time Low Change	339.51%
All Time Low Date	2019-05-30
ATR	8.38
Beta	0.92
Ch YTD	72.29
High	200
High52	200
High52 Date	2026-05-08
High52ch	-2.21%
Low	193.8
Low52	101
Low52 Date	2026-01-14
Low52ch	93.62%
Ma50ch	26.89%
Price vs 200-day SMA	46%
RSI	83.3
RSI Monthly	67.14
RSI Weekly	78.83
Sharpe ratio	0.85x
Sortino ratio	1.93
Total Return	14.33%
Tr YTD	72.29
Tr1m	30.41%
Tr1w	27.71%
Tr3m	39.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.6B
Operating Income Growth	6.67
Operating Income Growth Q	9.28
Operating Income Growth3 Y	17.31
Operating Income Growth5 Y	4
Operating margin	15.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,852,221%
Net Borrowing	647,181,602.7
Shares Insiders	2.24%
Shares Institutions	54.35%
Shares Qo Q	-3.35%
Shares Yo Y	-14.33%
Short Ratio	6.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1B
Average Volume	565.6x
Bv Per Share	-8.64
CAPEX	$-404.9M
Ch1m	30.41
Ch1w	27.71
Ch1y	36.33
Ch3m	39.42
Ch3y	121.9
Ch5y	55.48
Ch6m	59.55
Change	1.64%
Change From Open	-2.21
Close	192.4
Days Gap	3.93
Depreciation Amortization	525,728,555.2
Dollar Volume	35,595.6
Earnings Date	2026-05-05
EBIT	$1.6B
EBITDA	$2.1B
EPS	$8.13
F Score	6
FCF	$1.1B
FCF EV Yield	5.68x
Financing CF	-912,994,034
Fiscal Year End	December
Founded	1,994
Goodwill	5,561,732,737.9
Graham Number	67.93508
Graham Upside	-65.26
Income Tax	$231.1M
Investing CF	-478,542,544
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	$61.83
Lynch Upside	-68.39
Ma150	133.3
Ma150ch	46.75%
Ma20	157.1
Ma20ch	24.51%
Net CF	152,846,868
Open	200
P FCF Ratio	8.28
P OCF Ratio	6.1
Position In Range	29.17
Ppne	3,778,662,162.3
Price Date	2026-05-08
Price EBITDA	$4.43
Relative Volume	0.35x
Revenue	10,477,381,318x
SBC By Revenue	1x
Share Based Comp	104,776,176
Tax By Revenue	2.21x
Tax Rate	21.77%
Tr6m	59.55%
Volume	182
Z Score	1.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0I7E pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0I7E stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0I7E?

Insider, institutional, and short-interest positioning.

Institutional ownership

+54.4%

Share of float held by funds and institutions

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0I7E momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

83.3

Above 70: short-term overbought

Price vs 200-day MA

+46.0%

50/200-day relationship not available

Beta (5Y)

0.92

Moves roughly with the market

Sharpe ratio

0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0I7E

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0I7E stock rating?

lon/0I7E is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0I7E analysis?

The full report lives at /stocks/lon/0I7E/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0I7E?

The latest report frames lon/0I7E around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0I7E page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.